Clinical trials
Recruiting Ovarian Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
113 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2015 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 10 |
| 2022 | 12 |
| 2023 | 12 |
| 2024 | 23 |
| 2025 | 29 |
| 2026 | 22 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 113 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 4 |
| Beijing Biotech | 4 |
| Fudan University | 4 |
| Tongji Hospital | 4 |
| Bai-Rong Xia | 3 |
| Daiichi Sankyo | 3 |
| Eli Lilly and Company | 3 |
| Essen Biotech | 3 |
| Peking University Third Hospital | 3 |
| Second Affiliated Hospital of Guangzhou Medical University | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ovarian Neoplasms | 113 |
| Breast Neoplasms | 23 |
| Uterine Cervical Neoplasms | 22 |
| Endometrial Neoplasms | 20 |
| Pancreatic Neoplasms | 15 |
| Fallopian Tube Neoplasms | 14 |
| Neoplasm Metastasis | 12 |
| Colorectal Neoplasms | 11 |
| Stomach Neoplasms | 11 |
| Carcinoma, Non-Small-Cell Lung | 10 |
Trials
Showing 1 to 25 of 113. Each trial links to its page on Pharma Observatory.
13 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.